|
KMID : 0861120210250020001
|
|
Korean Journal of Oriental Preventive Medicine
2021 Volume.25 No. 2 p.1 ~ p.11
|
|
|
Concurrent Use of Korean Herbal Medicines and Western Chemical Medicines: Evidence from HIRA-NPS
|
|
Lee Hye-Jae
Yoon Nan-He
Park So-Hyun
Shin Seung-Won
Park Min-Jung
|
|
|
Abstract
|
|
|
Objective : The purpose of this study is to analyze Korean patients’ characteristics, who were concurrently treated with both Korean herbal medicines and Western chemical medicines using nation-wide database.
Method : Using the patients sample data (HIRA-NPS 2018) provided by Health Insurance Review and Assessment Service, a group of patients who co-administered Korean herbal and Western medicines was selected, and their basic characteristics, diagnosis, and prescribed chemical medicines were analyzed.
Results : Out of the 1,481,921 sample population, 17,629 patients (1.2%) were selected as a concurrent medication group. Compared to the whole sample, the concurrent medication group was composed of more women (65.8% vs. 51.1%), the more elderly people (65 or older years old) (44.5% vs. 14.6%), and the higher prevalence of chronic diseases (49.1% vs. 22.2%). The most frequent diagnosis treated with Western medicines was mental and behavioral disorders, musculoskeletal and circulatory disorders. Frequently used drugs among concurrent medication group were anti-anxiety drugs, gastric ulcer treatment drugs, and senile diseases treatment drugs.
Conclusion : The evidence reported in this study is expected to provide herb-drug interaction researchers with important reference to set the priorities of research topics in the future.
|
|
|
KEYWORD
|
|
|
Korean Medicine, National Health Insurance, Korean Herbal Medicine, Western Chemical Medicine, Concurrent Medication
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
|
|